Next Generation of Deep Brain Stimulation Aims to Tackle Depression

Two Leading Mount Sinai Brain Scientists Recognized for Outstanding Contributions to Neuropsychopharmacology

Two Leading Mount Sinai Brain Scientists Recognized for Outstanding Contributions to Neuropsychopharmacology

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

‘It is a flaw in our cells that becomes a flaw in love’: Doctor Siddhartha Mukherjee On the Search For a Cure for Depression

Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival

Two Leading Mount Sinai Brain Scientists Elected to the National Academy of Sciences

The Brain Changes Its Rhythm Within Minutes of Therapeutic Stimulation During Deep Brain Stimulation Surgery for Treatment-Resistant Depression

Mount Sinai Partners With Studio Elsewhere to Launch Q-Lab, an Immersive, Interactive Research and Restorative Care Environment for Deep Brain Stimulation Patients

Long-Term Follow-Up Data Shows Deep Brain Stimulation Is an Effective Treatment for Treatment-Resistant Depression

Philanthropic Gift to Mount Sinai Establishes The Lipschultz Center for Cognitive Neuroscience